This video from Boehringer Ingelheim Idiopathic Pulmonary Fibrosis shows how it is to live with IPF, how every single breath counts for the patients living with this disease. As read in the video description, for these patients, “it’s not about the number of breaths…
Every Breath Counts: Living with Idiopathic Pulmonary Fibrosis
Pulmonary fibrosis (PF) is a respiratory disease characterized by the presence of scarred tissue in the lungs. “It can be challenging to figure out what caused your pulmonary fibrosis. Sometimes doctors are able to identify one or more causes of your disease, but it is also common…
The Pulmonary Fibrosis Foundation (PFF) recently announced the launch of the PFF Patient Registry, which will comprise the foundation’s first comprehensive collection of data from pulmonary fibrosis (PF) patients across America. The first patient was enrolled last week, kicking off patient enrollment in the registry,…
In this video from MD Magazine TV, watch Dr. Danny McBryan, from Boehringer Ingelheim Pharmaceuticals, talk about the data his company published at CHEST, about how hard it is to find medications and treatments for IPF patients, and how having even one viable…
It’s known that genetics may be a cause of the development of pulmonary fibrosis, but in the majority of cases, the cause is unknown — a condition known as idiopathic pulmonary fibrosis. Each patient tends to have an individualized experience with the disease, which can progress faster or slower from…
PFF Care Center Network is a group of medical centers which dedicate their work to improving the lives of those living with pulmonary fibrosis. According to the Pulmonary Fibrosis Foundation, these kinds of centers are expanding and keep growing. Their main purpose is to treat patients with…
In this video from Cincinnati Children’s Hospital Medical Center, meet little Ghadah, a baby girl who suffers from a rare lung disease and needed a lung transplant. Parents do everything for their children, and that’s what Faleh Alrashidi, from Saudi Arabia, did. He searched for…
Antegrin Therapeutics recently announced that it is expanding its current medication portfolio to include anti-fibrosis agents that block proteins known as integrins. The drugs were originally discovered at the Center for World Health & Medicine (CWHM) at Saint Louis University. Antegrin already offers several medications that target conditions characterized by fibrosis, including pulmonary…
In this video from Gifted Life, watch Lauren answer eight questions about transplants that she usually gets asked about. Watch the full video to learn more about her transplant journey. Learn more about pulmonary fibrosis: https://bit.ly/1VElTQA…
In this video from CHEOvideos, watch Dr. Bernard Thébau, a physician in the Neonatal Intensive Care Unit at Children’s Hospital of Eastern Ontario, talk about the healing possibilities stem cells from umbilical cords can have to treat lung disease in premature newborns. Watch the…
